콘텐츠로 건너뛰기
SHOP
로고-5

    Hydrogen Water reduce Brain Damage

    Hydrogen Water reduce Brain Damage from Hypoxic-ischemic encephalopathy

    Hypoxic-ischemic encephalopathy (HIE) is a devastating condition, especially in newborns, that arises from a lack of oxygen to the brain.

    It can lead to lifelong neurological problems and even death. In this two-part series, we explore an innovative treatment approach using hydrogen water to combat HIE and its impact on specific biomarkers: neuron-specific enolase (NSE), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α).

    hypoxic-ischemic encephalopathy

    Background

    HIE is a significant concern worldwide, particularly in developing countries. It results from perinatal asphyxia, causing brain damage due to reduced or suspended blood flow to the brain. Inflammation plays a crucial role in the development of HIE, triggering a cascade of harmful effects in nerve cells. Elevated levels of IL-6, TNF-α, and NSE in the blood are indicative of the severity of HIE.

    Current Treatment Challenges:

    While various treatments for HIE have been explored, comprehensive therapy is often recommended. However, these treatments can be expensive, controversial, or have limited effectiveness. Identifying a cost-effective, targeted treatment is essential for improving outcomes in newborns with HIE.

    Hydrogen Water as a Potential Solution for Hypoxic-ischemic Encephalopathy

    시간ydrogen water, enriched with hydrogen ions, has shown promise as a therapeutic agent due to its potent antioxidant properties. It can effectively neutralize harmful reactive oxygen species (free radicals) in the body without side effects. Previous studies have demonstrated its efficacy in conditions like senile dementia, cardiovascular diseases, and arteriosclerosis. Our Study: Since 2014, hydrogen water has been utilized in the treatment of HIE at the Affiliated Hospital of Taishan Medical University with positive outcomes. Our study retrospectively analyzed its therapeutic effects on neonatal HIE and its protective mechanisms by measuring serum NSE, IL-6, and TNF-α levels before and after treatment.

    Results and Conclusion

    Our analysis revealed that the hydrogen water group exhibited significantly lower efficacy indicators compared to the conventional group. Serum NSE, IL-6, and TNF-α levels, which were elevated in HIE patients before treatment, decreased notably after hydrogen water therapy. This suggests that hydrogen water may play a protective role in reducing these biomarkers and potentially improving outcomes in HIE newborns. HIE is a significant health concern, particularly in developing countries like China. Our study suggests that hydrogen water could be a valuable addition to HIE treatment protocols, offering a cost-effective and safe option for reducing inflammation and improving outcomes for newborns. Further research is needed to explore its full potential in clinical settings.

    Reference
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329859

    태그:
    ionfarms-로고
    세계 최고의 수소수 생성기

    CS 서비스

    기타 사업

    연락처 세부 정보

    © 2022 H2CAP. 판권 소유.
    페이스북 트위터 인스 타 그램 유튜브
    ko_KR한국어
    ko_KR한국어 en_USEnglish es_ESEspañol zh_CN简体中文 arالعربية hi_INहिन्दी de_DEDeutsch fr_FRFrançais it_ITItaliano pt_PTPortuguês nl_NLNederlands pl_PLPolski cs_CZČeština sv_SESvenska ru_RUРусский tr_TRTürkçe ja日本語 id_IDBahasa Indonesia thไทย viTiếng Việt